Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Curr Oncol 2013 Aug 01;204:e283-8. doi: 10.3747/co.20.1380.
Show Gene links Show Anatomy links

Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer.

Morgillo F , De Vita F , Antoniol G , Orditura M , Auriemma PP , Diadema MR , Lieto E , Savastano B , Festino L , Laterza MM , Fabozzi A , Ventriglia J , Petrillo A , Ciardiello F , Barbarisi A , Iovino F .

Increased insulin-like growth factor (igf) signalling has been observed in breast cancer, including endocrine-responsive cancers, and has been linked to disease progression and recurrence. In particular, igf-1 has the ability to induce and promote lymphangiogenesis through the induction of vascular endothelial growth factor C (vegfc). In the present study, we analyzed serum and tumour samples from 60 patients with endocrine-positive breast cancer to determine the expression and the possible relationship of circulating igf-1, igf binding protein 3 (igfbp3), and vegfc with the presence of lymphatic metastasis and other immunohistochemical parameters. The analysis revealed a clear and significant correlation between high basal levels of igf-1, igfbp3, and vegfc and lymph node metastasis in endocrine-responsive breast cancer. In addition, expression of those molecules was significantly higher in breast cancer patients than in healthy control subjects. Those findings may enable more accurate prediction of prognosis in patients with breast cancer.

PubMed ID: 23904766
PMC ID: PMC3728056
Article link: Curr Oncol

Genes referenced: LOC100889856 LOC105439578 LOC105439585 nodall vegfc

References [+] :
Björndahl, Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. 2005, Pubmed